Abstract
Background: Gastric cancer is a global health issue, and
efforts are being made to discover new compounds that can be used to treat
or prevent this disease. Clove (Syzygium aromaticum) contains eugenol and
other bioactive compounds that have antioxidant and anticancer effects. The
use of nanoemulsion technology can help to improve the solubility, stability, and
bioavailability of these natural compounds, which in turn may enhance their
therapeutic ability. Objective: This study aimed to compare the chemical
composition and anticancer activity of clove oil nanoemulsions and alcoholic
clove extract against human gastric cancer cells. Methods: Both clove oil
nanoemulsion and alcoholic extract were prepared using standardized methods,
with 50% ethanol employed for the extraction of active compounds. The
samples were characterized by dynamic light scattering (DLS) for particle size
analysis and Fourier-transform infrared spectroscopy (FTIR) for identification
of functional groups and structural features. Their anticancer activity was
evaluated using the MTT assay on a gastric cancer cell line by testing multiple
concentrations and assessing effects on cell viability. Results: FTIR analysis
revealed the presence of key functional groups in both the nanoemulsion
and the alcoholic extract, such as phenolic hydroxyl groups (O–H) and aromatic
bonds (C=C), confirming the presence of eugenol as the main active
ingredient in both preparations. However, the nanoemulsion exhibited higher
spectral intensity and a better distribution of nonpolar compounds, indicating
improved solubility and stability of the active compounds. Both samples
demonstrated antioxidant activity and the ability to inhibit the growth of gastric
cancer cells. The nanoemulsion was found to have significantly higher
potency compared to the alcoholic extract, with an IC50 value of 36.30±1.47
μg/mL compared to 41.67±1.53 μg/mL for the extract. Conclusions: This
difference is attributable to enhanced solubility, stability and cellular uptake of
the active compounds in the nanoemulsion. The results suggest that clove oil
nanoemulsions exhibit superior antioxidant properties and anticancer activity
compared to conventional alcoholic extracts indicating that nanotechnology and
traditional methods together present a unique opportunity for improving bioactivity
and bioavailability of natural anticancer agents, which could lead to the
development of effective therapies as treatment options for gastric cancer.
efforts are being made to discover new compounds that can be used to treat
or prevent this disease. Clove (Syzygium aromaticum) contains eugenol and
other bioactive compounds that have antioxidant and anticancer effects. The
use of nanoemulsion technology can help to improve the solubility, stability, and
bioavailability of these natural compounds, which in turn may enhance their
therapeutic ability. Objective: This study aimed to compare the chemical
composition and anticancer activity of clove oil nanoemulsions and alcoholic
clove extract against human gastric cancer cells. Methods: Both clove oil
nanoemulsion and alcoholic extract were prepared using standardized methods,
with 50% ethanol employed for the extraction of active compounds. The
samples were characterized by dynamic light scattering (DLS) for particle size
analysis and Fourier-transform infrared spectroscopy (FTIR) for identification
of functional groups and structural features. Their anticancer activity was
evaluated using the MTT assay on a gastric cancer cell line by testing multiple
concentrations and assessing effects on cell viability. Results: FTIR analysis
revealed the presence of key functional groups in both the nanoemulsion
and the alcoholic extract, such as phenolic hydroxyl groups (O–H) and aromatic
bonds (C=C), confirming the presence of eugenol as the main active
ingredient in both preparations. However, the nanoemulsion exhibited higher
spectral intensity and a better distribution of nonpolar compounds, indicating
improved solubility and stability of the active compounds. Both samples
demonstrated antioxidant activity and the ability to inhibit the growth of gastric
cancer cells. The nanoemulsion was found to have significantly higher
potency compared to the alcoholic extract, with an IC50 value of 36.30±1.47
μg/mL compared to 41.67±1.53 μg/mL for the extract. Conclusions: This
difference is attributable to enhanced solubility, stability and cellular uptake of
the active compounds in the nanoemulsion. The results suggest that clove oil
nanoemulsions exhibit superior antioxidant properties and anticancer activity
compared to conventional alcoholic extracts indicating that nanotechnology and
traditional methods together present a unique opportunity for improving bioactivity
and bioavailability of natural anticancer agents, which could lead to the
development of effective therapies as treatment options for gastric cancer.
Keywords
Alcoholic extract; Clove oil; Nanoemulsion; Anticancer activity; Gastric Cancer Cells